As the Chief AI Officer at USDM Life Sciences, John Petrakis leverages over 30 years of extensive global industry experience to drive transformative initiatives across the pharmaceutical, biotech, and medical device sectors. His current role is pivotal in defining and implementing a comprehensive AI strategy...
As the Chief AI Officer at USDM Life Sciences, John Petrakis leverages over 30 years of extensive global industry experience to drive transformative initiatives across the pharmaceutical, biotech, and medical device sectors. His current role is pivotal in defining and implementing a comprehensive AI strategy that aligns seamlessly with USDM’s overarching business objectives. John’s expertise in developing AI and machine learning-driven products not only enhances operational efficiency but also addresses the regulatory and quality pressures that are inherent in these industries.
John is currently spearheading key projects that focus on optimizing internal performance through advanced data analytics and AI model governance. His leadership in fostering strategic partnerships has been instrumental in creating a collaborative ecosystem that encourages innovation and accelerates the development of cutting-edge solutions. With a strong commitment to compliance and ethical standards in AI usage, John ensures that all AI initiatives adhere to the highest regulatory requirements, thereby safeguarding patient safety and data integrity.
In addition to his technical acumen, John is recognized for his thought leadership in the AI space, contributing to industry discussions and promoting continuous learning within his teams. His skills in business analysis, project portfolio management, and business process re-engineering enable him to deliver significant value and drive sustainable growth in a rapidly evolving landscape. As a leader, John Petrakis exemplifies the integration of technology and compliance, positioning USDM Life Sciences at the forefront of innovation in the life sciences sector.
